1. Introduction {#sec1}
===============

Cervicogenic headache (CeH) is a common diagnosis for patients with unilateral referred pain to the head from the upper cervical spine \[[@B1]\]. The prevalence of CeH has been estimated at up to 20% among patients with chronic headaches \[[@B2]\]. Treatment strategies for CeH are wide and varied, such as medication, physical therapy, acupuncture, manipulation, transcutaneous electrical nerve stimulation, pulsed radiorefrequency, injections, and surgery \[[@B3], [@B4]\]. The majority of patients preferred to choose the noninvasive strategies, including physical and manual therapies, activity modification, and various medication trials before considering anesthetic blocks \[[@B1], [@B2], [@B5]--[@B7]\]. There is an ongoing need for evidences of long-term effect and high-quality randomized controlled trail investigations for these strategies.

The C~2~-C~3~ zygapophysial and atlantoaxial joints are believed to be primary causes for CeH and the C~2~ nerve may be more susceptible to injury by aseptic inflammation or compression than the other structures \[[@B3]\]. Thus, several local anesthetic techniques have been used in treating CeH, including occipital nerve blocks, cervical facet joint blocks, and cervical epidural injections \[[@B8]--[@B11]\]. Real time fluoroscopy imaging guidance is frequently required to ensure correct needle placement \[[@B12]--[@B14]\]. However, repeated exposure to radiation is a great threat to the health of physicians. Ultrasound-guided injections have been described recently in the literatures, and the absence of radiation exposure, equipment affordability, and bedside setting are advantages of ultrasonography compared with traditional radiological imaging \[[@B15]--[@B18]\].

The objective of this study was to evaluate the efficacy of ultrasound-guided deep cervical plexus block for patients with CeH in comparison with fluoroscopy-guided block through a prospective, randomized, single-blind clinical trial.

2. Materials and Methods {#sec2}
========================

There were 84 eligible patients with CeH and 60 patients participated in this randomized, single-blind study. They were enrolled and then randomly assigned into two groups according to a random number table and underwent ultrasound-guided (US, *n* = 30) or fluoroscopy-guided (FL, *n* = 30) C~2~ and/or C~3~ transverse process injection, respectively, in the pain center of Sun Yat-sen Memorial Hospital from July 2011 to January 2014. The study was approved by our university and all patients gave informed consent before this study.

The patients had experienced screening that included medical history and physical examination followed by X-ray, CT scan, or MRI of the cervical spine. All patients were diagnosed with CeH according to the diagnostic criteria of Sjaastad et al. \[[@B19]\]: (1) unilateral or bilateral pain starting in the neck and radiating to the frontotemporal region, (2) pain aggravated by neck movement, (3) restricted cervical range of motion, (4) joint tenderness in at least one of the joints of the upper cervical spine (C~2~-C~3~), and (5) headache frequency of at least 1 per week over a period greater than 3 months. In this study, we chose the patients with unilateral pain. Our exclusion criteria included (1) pathologic fracture, cancer, and other diseases of the cervical vertebra, (2) headache caused by nervous system diseases, or other factors.

2.1. US-Guided Blockade Procedures {#sec2.1}
----------------------------------

The patients were placed in sitting position with the neck bending forward and the head was supported ([Figure 1(a)](#fig1){ref-type="fig"}). The selection of the site for injection was determined by first having the patient identify the more painful side \[[@B8], [@B11]\]. An Esaote MyLab60 (Esaote, Italy) ultrasound machine equipped with a multifrequency linear probe (4--13 MHz) was used. The skin was prepared with betadine and draped in the usual sterile fashion at the region of injection. The ultrasound probe was also sterilized with betadine. On the transverse section, the spinal process of C~2~ or C~3~ was identified on the ultrasound image ([Figure 1(b)](#fig1){ref-type="fig"}). Then, the probe was moved laterally from midline and the posterior elements, including layers of muscle, lamina, interlaminar space, facet joint, C~2~ or C~3~ transverse process, and vertebral artery that were identified on the transverse sonograms at the same level ([Figure 2](#fig2){ref-type="fig"}). A 22-gauge 3.5-inch spinal needle was inserted to C~2~ or C~3~ transverse process (Figures [3(a)](#fig3){ref-type="fig"} and [3(b)](#fig3){ref-type="fig"}). When the needle reached the bone, after negative aspiration, total 2--4 mL of 1% lidocaine with 7 mg of betamethasone was injected in slow speed while maintaining communication and questioning of the patient to ensure that the needle was not intravascular or intrathecal. If the headache was unilateral in nature, the block was performed only on the affected side (C~2~ and/or C~3~). If necessary, the patients would receive the second injection in one-week interval after the first injection. All procedures were performed in the same fashion by C. M and HY. Y.

2.2. FL-Guided Blockade Procedures {#sec2.2}
----------------------------------

The patients were placed in supine and, using external landmarks, the C~2~ or C~3~ spinal process was identified on the lateral view ([Figure 4](#fig4){ref-type="fig"}). After routine skin preparation and sterilization, a 22-gauge 3.5-inch spinal needle was inserted into the lateral recess of C~2~-C~3~ and its position was confirmed in the AP and lateral projections ([Figure 5](#fig5){ref-type="fig"}). All procedures were performed by the same physician Q. W. In one week at the return visit, the physician applied the second block treatment if necessary, depending on the symptom of patients.

2.3. Outcome Assessment {#sec2.3}
-----------------------

The measurement of pain was evaluated by patients\' ratings of a 10-point numerical pain scale (NPS, from 0, no pain, to 10, the worst pain). Pain was assessed before the injection and the return visit was conducted in 2 weeks after treatment to exclude any major complications. All the patients were followed up at 12-week and 24-week intervals with telephone consultation and visits to the pain clinic.

2.4. Data Analysis {#sec2.4}
------------------

The pain intensities were measured on a 0--10 NPS. The characteristics of the US and FL groups such as sex, age, and duration of pain were compared by the *χ*^2^ test and Mann--Whitney *U* method. At each time point of injection, the NPS was compared by repeated-measures analysis of variance, and the Bonferroni correction was conducted for post hoc comparison. Statistical analysis was carried out using SPSS 16.0 (SPSS Inc., Chicago, IL, USA). Values are expressed as means ± SD and a*P* value of less than 0.05 was considered to be statistically significant.

3. Results {#sec3}
==========

3.1. Patient Characteristics {#sec3.1}
----------------------------

A total of 84 consecutive patients were assessed for eligibility during this study, with 60 of them being enrolled and 54 patients completing the study. A flow diagram with patient selection and follow-up is presented in [Figure 6](#fig6){ref-type="fig"}. In US group, two patients lost track in the follow-up and the other patients (*n* = 28, 7 males and 21 females) completed the injection and 12 patients received the second injection treatment. In FL group, one patient chose other noninvasive interventions and three patients were lost in the follow-up because of refusal to radiation exposure; a total of 26 patients (5 males and 21 females) completed this study and one-half of them received the second block. The patients had comparable pain duration for 10.06 ± 3.47 months as that of US group. The majority of location of the block was the C2 transverse process (71.43% in US group and 80.77% in FL group). The demographic data of patients are present in [Table 1](#tab1){ref-type="table"}.

3.2. Treatment Effects between the Approaches {#sec3.2}
---------------------------------------------

The blocking procedures were tolerable for all the patients during the treatment. However, 3 patients in US group felt dizzy immediately after injection; the symptom disappeared when they lay down on the bed for several minutes. A total of 4 patients (2 in US group and 2 in FL group) complained of neck and shoulder uncomfortableness. None of the patients in this study had any treatment-related severe complications. There were 25 patients (12 in US group and 13 in FL group) who received the second injection according to their symptoms at the return visit.

There were no significant differences observed in the NPS before and 2 wks, 12 wks, and 24 wks after the injections between US and FL groups ([Table 2](#tab2){ref-type="table"}). The pain intensity, as measured by NPS, significantly decreased at 2 wks after injection treatment in both US and FL groups, respectively, compared with that of baseline (*P* \< 0.05). The blocking procedures had continued, and comparable pain relieving effects appeared at 12 wks and 24 wks after treatment in both US and FL groups ([Table 2](#tab2){ref-type="table"}), the NPS score significantly decreased 12 wks and 24 wks after treatment compared with that at baseline (*P* \< 0.05) and at 2 wks after injection (*P* \< 0.05). It indicated that steroid injection guided by either ultrasound or fluoroscopy had sustained pain-relieving effect for CeH patients.

4. Discussion {#sec4}
=============

Cervicogenic headache is a common clinical syndrome and few conservative managements lead to satisfactory clinical efficacy. There are multiple causes of CeH, including the C~2~-C~3~ and C~3~-C~4~ z-joints, A-A joint, C~2~-C~3~ intervertebral disk, A-O joint, and the greater or lesser occipital nerve \[[@B1]\]. Anatomically, the main dorsal ramus of C~2~ becomes the greater occipital nerve after passing the posterior aspect of the C~1/2~ facet joint. The C~2~ and C~3~ ventral rami become the lesser occipital nerve, and the C~3~ dorsal ramus becomes the third occipital nerve \[[@B1], [@B2], [@B8], [@B11]\]. The pain of CeH most commonly originates from the C~2/3~ facet joints \[[@B20]\]. In this study, US or FL-guided C~2~ and/or C~3~ transverse process steroid injections were applied to 54 patients with CeH and comparable pain relief effect was observed. It has been frequently demonstrated that blockade of the greater occipital nerve, the lesser occipital nerve, the stellate ganglion, and other various blocking treatments are effective strategies for CeH. Zhou et al. reported that, of the 28 CeH patients, 26 of them had abnormalities in the cervical spine below the C~1/2~ and C~2/3~ levels and C~1/2~, C~2/3~ facet joint injections and C~2~, C~3~ spinal rami blocks were effective and well tolerated by the patients \[[@B8]\]. Anthony reported that injection of methylprednisolone into the greater and lesser occipital nerve region could relieve headache completely in 169 out of 180 patients for a duration of 10--77 days \[[@B21]\]. Our results also showed sustained pain relief effect of steroid injections for as long as 6 months; however, these results were inconsistent with those of Goldberg et al. \[[@B11]\]. The authors applied FL-guided deep cervical plexus block to 39 patients with CeH; the mean pain scores were significantly lower than baseline at 3 months but by 6 months the pain had returned to pretreatment levels. One possible explanation could be the difference in inclusion criteria; the study of Goldberg et al. recruited patients suffering from atypical headaches for longer duration of 4-5 years, while it were typical CeH patients with the symptoms only for 5.7--13.5 months in our study. Another factor contributing to the varied results could be frequency of injection treatment for patients with longer and shorter history. Our patients with a history for 5.7--13.5 months received 1-2 blockade treatments, while the great majority of patients (87%) with a history for more than 4 years in their study only had a median treatment frequency for 2 injections. For patients with longer history of CeH, more treatment sessions might be considered for longer pain relief effect.

The C~2~ and/or C~3~ transverse process block technique is a modification of the deep cervical plexus block that has been utilized to provide anesthesia to the head and neck region \[[@B15]\]. This technique is relatively safe since the cervical foramen is not entered and vertebral artery ([Figure 2](#fig2){ref-type="fig"}) can easily be detected by ultrasonography. Although this block occurred more peripherally compared to z-joint and transforaminal block, our results demonstrated that the blocking strategy has efficient pain relief effect. The analgetic solution spreads within the cervical region to adjacent levels since the paravertebral space communicates freely \[[@B24]\], which allows local injection at one level that can achieve the same beneficial effect.

The FL-guided injection procedure is most commonly used in treating pain-associated diseases to ensure correct needle placement. However, radiation exposure was unavoidable, and there is a risk of vertebral artery injury. The US-guided method has several advantages in comparison with the FL-guided method. Gofeld et al. explored US-guided lumbar transforaminal and z-joint injection techniques for patients with spinal pain, and their studies demonstrated that US-guided injections are accurate and feasible \[[@B22], [@B23]\]. It has also been reported that US-guided selective nerve root block and caudal injection for low back pain are feasible, easy-to-perform, and effective procedures \[[@B15], [@B18]\]. Ultrasonography may be a viable alternative to fluoroscopy or computed tomography as a guidance method, because it overcomes the disadvantages of radiation exposure and poor vascular display. Furthermore, the device of ultrasonography is portable and convenient to be used at bedside for patients with severe pain.

The main limitations of the study are as follows: first, the sample size was small; thus, clinical findings still need to be confirmed with larger clinical trials. Second, this study was not a double-blind control study. It was difficult to conduct a double-blind control study with nontraditional modalities such as ultrasound and fluoroscopy. Additional investigations may be needed to improve the limitations.

In summary, deep cervical plexus block in C~2~ or C~3~ transverse process for treating patients with cervicogenic headache provided significant and prolonged pain relief (6 months\' follow-up). The US-guided approach showed similar satisfactory effect as the FL-guided block. Ultrasonography can be an alternative method for its convenience and efficacy in deep cervical plexus block without radiation exposure.
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![(a) The position of the patient. (b) Transverse ultrasound view of C~2~ spinal process (SP), spinal canal (SC), and vertebral lamina (VL).](BMRI2017-4654803.001){#fig1}

![Transverse ultrasound view of C~2~ transverse process (TP), vertebral artery (VA), and carotid artery (CA) (left side).](BMRI2017-4654803.002){#fig2}

![(a) Ultrasound-guided C~2~ transverse process block (left side). (b) The needle is targeted just lateral to the transverse process (TP) (left side).](BMRI2017-4654803.003){#fig3}

![The C~2~ or C~3~ spinal process is identified on the lateral view under fluoroscopy guidance with external landmarks.](BMRI2017-4654803.004){#fig4}

![The position of needle is confirmed in the lateral projection.](BMRI2017-4654803.005){#fig5}

![Schematic presentation of participant flow.](BMRI2017-4654803.006){#fig6}

###### 

General characteristics of the patients.

                         US (*n* = 28)   FL (*n* = 26)   *P*
  ---------------------- --------------- --------------- -------
  Age                    49.2 ± 10.3     47.6 ± 9.7      0.419
  Gender                                                 0.747
   Male                  7               5                
   Female                21              21               
  Duration (mos)         9.35 ± 3.68     10.06 ± 3.47    0.725
  Pain side                                              0.781
   Left                  10              11               
   Right                 18              15               
  Number of injections                                   0.785
   1                     16              13               
   2                     12              13               
  Injection position                                     0.530
   C~2~                  20              21               
   C~3~                  8               5                

###### 

Comparison of the NRS before and after treatment.

             US                 FL
  ---------- ------------------ ------------------
  Baseline   7.61 ± 1.12        7.50 ± 1.06
  2 wks      3.45 ± 0.54^a^     3.40 ± 0.58^a^
  12 wks     2.41 ± 0.62^a,b^   2.39 ± 0.68^a,b^
  24 wks     2.36 ± 0.56^a,b^   2.43 ± 0.59^a,b^

^a^Significantly different from the baseline at *P* \< 0.05.

^b^Significantly different from 2 wks after treatment at *P* \< 0.05.
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